G Stoa Birketvedt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

G Stoa Birketvedt

Showing results (1-10 of 1) with videos related to

Pageof 1

Sort By:

Diabetologia|July 8, 2005

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic populationB Fagerberg, S Edwards, T Halmos, et al.

Pageof 1

Search research articles

Showing results (1-10 of 1) with videos related to

Sort By:

Pageof 1

Diabetologia|July 8, 2005

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic populationB Fagerberg, S Edwards, T Halmos, et al.

Pageof 1